Dopo l'orario di chiusura: 10.11 -0.13 -1.27%

Iovance Biotherapeutics Inc (IOVA)

Iovance Biotherapeutics Inc Borsa (IOVA) Ultime notizie

Iovance Biotherapeutics Inc (IOVA)

Iovance Biotherapeutics Inc Borsa (IOVA) Ultime notizie

Reviewing Iovance Biotherapeutics (NASDAQ:IOVA) & Vaxart (NASDAQ:VXRT) - Defense World

Why Iovance Biotherapeutics (IOVA) Shares Are Exploding Higher - MSN

Amgen’s Imdelltra Becomes First Bi-specific T-cell engager for Advanced SCLC - BioSpace

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Amgen’s Imdelltra Becomes First Bi-specific T-cell engager for Advanced SCLC - BioSpace

BMS’s Breyanzi Secures Fourth FDA Approval, for Follicular Lymphoma - BioSpace

BMS’s Breyanzi Secures Fourth FDA Approval, for Follicular Lymphoma - BioSpace

4 Small-Cap Value Stocks That Could Go Parabolic

How To Trade (IOVA) - Stock Traders Daily

Iovance (IOVA) Q1 Loss Wider Than Expected, Revenues Nil - Yahoo News UK

BMS’s Breyanzi Secures Fourth FDA Approval, for Follicular Lymphoma - BioSpace

Looking At Iovance Biotherapeutics's Recent Unusual Options Activity - Iovance Biotherapeutics (NASDAQ:IO - Benzinga

Iovance Biotherapeutics' Amtagvi: Innovative Therapy, Financial Strain (Downgrade) (IOVA) - Seeking Alpha

HC Wainwright Reiterates “Buy” Rating for Iovance Biotherapeutics (NASDAQ:IOVA) - Defense World

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Down to $13.45 - Defense World

IOVA (Iovance Biotherapeutics) Net Issuance of Preferred St - GuruFocus.com

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Down to $13.45 - MarketBeat

Iovance Biotherapeutics (NASDAQ:IOVA) Earns "Buy" Rating from HC Wainwright - MarketBeat

Earnings call: Iovance Biotherapeutics posts Q1 2024 results By Investing.com - Investing.com

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript - Insider Monkey

Iovance Q1 Earnings Review: Not Enough Data To Draw Conclusions On Amtagvi (NASDAQ:IOVA) - Seeking Alpha

Why Iovance Stock Is Down 18% Today - Yahoo Finance

Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ... - Yahoo Finance

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript - Insider Monkey

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript - Yahoo Finance

Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking - Iovance Biotherapeutics (NA - Benzinga

Iovance Biotherapeutics Reports a Q1 Revenue Miss

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates - Yahoo Finance

Iovance Biotherapeutics: Q1 Earnings Snapshot - Darien Times

Why Iovance Stock Is Down 18% Today - Yahoo Finance

Iovance Biotherapeutics: Q1 Earnings Snapshot | News | bakersfield.com - The Bakersfield Californian

Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates - GlobeNewswire

Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates - Yahoo Finance

Iovance Biotherapeutics: Q1 Earnings Snapshot - Darien Times

Iovance Biotherapeutics (IOVA) to Release Earnings on Thursday - Defense World

Investors Purchase Large Volume of Call Options on Iovance Biotherapeutics (NASDAQ:IOVA) - Defense World

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect - Yahoo Finance

Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect - Yahoo Finance

Got $500? These Hot Growth Stocks Are Screaming Buys Right Now

June 14th Options Now Available For Iovance Biotherapeutics (IOVA) - Nasdaq

Great week for Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) institutional investors after losing 43% over the previous ... - Yahoo Lifestyle UK

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Sees Significant Increase in Short Interest - Defense World

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Purchased by Handelsbanken Fonder AB - Defense World

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May ... - GlobeNewswire

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May ... - GlobeNewswire

Bailard Inc. Buys Shares of 12700 Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World

Iovance Biotherapeutics to Present at Upcoming Conferences - GlobeNewswire

Simile a IOVA